試す 金 - 無料
BREAKING THE PARKINSON'S PARADIGM INNOVATIONS SHIFTING FROM SYMPTOM CONTROL TO DISEASE MODIFICATION
Healthcare Radius
|April 2025
The combination of advanced diagnostics, targeted treatments, and innovative technologies like AI is paving the way for a future where Parkinson's can be managed more effectively—or even cured.

Parkinson's disease treatment is changing rapidly. New technology and treatment methods are helping doctors detect the disease earlier and manage symptoms better, offering hope to millions of patients worldwide.
Wearable devices now measure tremors more accurately, allowing doctors to distinguish Parkinson's from other movement disorders. Medical-grade wearables track symptoms continuously, while smartphone apps analyze tremor patterns. These tools provide objective data that complements clinical assessments and improves diagnostic accuracy.
Treatment approaches are moving beyond symptom control. New medications provide more stable relief with fewer side effects. More importantly, research now focuses on slowing the disease itself by targeting proteins like alpha-synuclein that build up in the brain. Gene therapy and neurotrophic factors represent promising avenues for restoring dopaminergic function.
Team-based care has become essential. While neurologists lead treatment, physical therapists, speech therapists, and mental health professionals all play key roles in managing different aspects of the disease. This comprehensive approach addresses both motor and non-motor symptoms.
Telemedicine is making specialist care more accessible, especially for patients in remote areas. Remote monitoring through wearable devices allows tracking of symptoms between visits and timely treatment adjustments. Despite these advances, challenges remain in technology access for older patients and inconsistent insurance coverage.
Dr. Parthasarathy B, Consultant Neurologist at Apollo Adlux Hospital Angamaly, shares valuable insights on these developments, providing useful information for healthcare providers and industry professionals working in neurology.
EXCERPT:
このストーリーは、Healthcare Radius の April 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、9,500 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Healthcare Radius からのその他のストーリー

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size